| View |
|
DR-XY4233
|
Tramadol Hydrochloride
|
Tramal
|
50mg/mL (100mg/2mL)
|
Solution For Injection
|
Opioid Analgesic
|
Grunethal GmbH
|
Germany
|
Automatic Renewal
|
07 September 2022
|
26 November 2027
|
| View |
|
DR-XY42331
|
Levocetirizine hydrochloride
|
Levoriz
|
5 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Pharmatec Pakistan (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
08 December 2022
|
29 July 2028
|
| View |
|
DR-XY42355
|
Sildenafil (As Citrate)
|
Speedgra
|
50mg
|
Film-Coated Tablet
|
Drugs Used For Erectile Dysfunction
|
Bal Pharma Limited
|
India
|
Automatic Renewal
|
11 May 2023
|
01 August 2028
|
| View |
|
DR-XY42370
|
Rocuronium Bromide
|
Neumeron
|
10mg/mL
|
Solution For Injection (Iv)
|
Neuromuscular Blockers (Non-depolarizing Agent)
|
Gland Pharma Limited
|
India
|
Automatic Renewal
|
21 July 2023
|
12 August 2028
|
| View |
|
DR-XY42371
|
Diclofenac Potassium
|
Atornac K
|
50 mg
|
Enteric-Coated Tablet
|
-
|
Pell Tech Health Care Pvt. Ltd.
|
India
|
-
|
04 September 2020
|
14 August 2025
|
| View |
|
DR-XY42374
|
Valsartan
|
Diovac
|
160 mg
|
Film-Coated Tablet
|
Angiotensin-2-Receptor Blocker (ARB)
|
Standard Chemical and Pharmaceutical Co., Ltd.
|
Taiwan
|
Automatic Renewal
|
29 July 2023
|
06 August 2028
|
| View |
|
DR-XY42375
|
5% Dextrose in Water
|
None
|
5% w/v
|
Solution For Iv Infusion
|
Fluid and electrolyte replenisher
|
Fresenius Kabi Oncology Ltd.
|
Germany
|
Automatic Renewal
|
21 June 2023
|
06 August 2028
|
| View |
|
DR-XY42377
|
Heparin (as Sodium)
|
Ceparin
|
5,000IU/mL ( 25,000 IU/5mL )
|
Solution For Injection
|
Antithrombotic Agent
|
North China Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
15 December 2017
|
06 August 2028
|
| View |
|
DR-XY42380
|
L-Asparaginase
|
L-Aspase
|
10,000 IU
|
Lyophilized Powder for Injection (IM/IV)
|
-
|
Naprod Life Sciences Pvt. Ltd.
|
India
|
-
|
30 October 2020
|
06 August 2025
|
| View |
|
DR-XY42381
|
Citicoline (as sodium)
|
Maxcolin
|
250 mg/mL
|
Solution for Injection (IM/IV)
|
Psychostimulant and Nootropic
|
Kamla Life Sciences Limited
|
India
|
Initial (Variation)
|
06 February 2024
|
06 February 2029
|
| View |
|
DR-XY42382
|
Calcium gluconate
|
Cal-C
|
100mg/mL (10% w/v)
|
Solution For Injection (IV)
|
Electrolyte
|
Jinling Pharmaceutical Co., Ltd. Zhejiang Tianfeng Pharmaceutical Factory
|
China
|
Renewal
|
17 August 2023
|
06 August 2028
|
| View |
|
DR-XY42383
|
Donepezil Hydrochloride
|
Aricept
|
23 mg
|
Film-Coated Tablet
|
Anticholinesterase
|
Eisai Co., Ltd
|
Japan
|
Automatic Renewal
|
05 January 2023
|
29 August 2028
|
| View |
|
DR-XY42391
|
Ondansetron
|
Onsetron
|
2 mg/mL
|
Solution For Injection
|
ANTIEMETICS AND ANTINAUSEANTS (SEROTONIN (5H ANTAGONIST)
|
Zee Laboratories
|
India
|
Automatic Renewal
|
26 July 2023
|
08 August 2028
|
| View |
|
DR-XY42393
|
Dulcolax
|
Bisacodyl
|
5 mg
|
Enteric-Coated Tablet
|
Laxative
|
PT. Boehringer Ingelheim Indonesia
|
Indonesia
|
Automatic Renewal
|
06 June 2023
|
08 August 2028
|
| View |
|
DR-XY42394
|
Doxorubicin Hydrochloride
|
Doxonish-50
|
50mg
|
Lyophilized Powder For Iv Injection/Infusion
|
Antineoplastic (Cell-Cycle-Specific Agent)
|
Admac Lifesciences
|
India
|
Renewal
|
13 March 2023
|
08 August 2028
|
| View |
|
DR-XY42407
|
Telmisartan + Hydrochlorothiazide
|
Telday 40 H
|
40 mg / 12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Torrent Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
10 May 2023
|
08 August 2028
|
| View |
|
DR-XY42408
|
Telmisartan + Hydrochlorothiazide
|
Telday 80 H
|
80 mg/12.5 mg
|
Tablet
|
ANGIOTENSIN II RECEPTOR BLOCKER
|
TORRENT PHARMACEUTICALS LTD.
|
India
|
Automatic Renewal
|
10 May 2023
|
08 August 2028
|
| View |
|
DR-XY42423
|
Zoledronic Acid
|
ZOBONE 5
|
5 mg/100 mL
|
Solution For Injection (I.V. Infusion)
|
-
|
Sun Pharmaceutical Industries Ltd.,
|
India
|
Automatic Renewal
|
19 February 2023
|
13 August 2028
|
| View |
|
DR-XY42424
|
Ascorbic Acid + Zinc
|
Immunpro
|
500mg (equivalent to 562.43 mg Sodium Ascorbate)/ 10mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Film-Coated Tablet
|
Vitamin & Mineral
|
UNILAB, Inc.
|
Philippines
|
Automatic Renewal
|
15 June 2023
|
24 September 2028
|
| View |
|
DR-XY42426
|
Ondansetron (as Hydrochloride Dihydrate)
|
Onsia
|
2 mg/mL (8 mg/4 mL)
|
Solution for Injection (I.M/I.V)
|
Antiemetic {Serotonin (5HT3) Antagonist}
|
Siam Bheasach Co., Ltd.
|
Thailand
|
Initial (Variation)
|
24 August 2023
|
24 August 2028
|